Vytrus Biotech

Vytrus Biotech CROIC

The Cash Return on Invested Capital (CROIC) of Vytrus Biotech (VYT.MC) as of Oct 30, 2026 is 10.30 %. In the previous year, Cash Return on Invested Capital (CROIC) was 6.90 % — a change of 49.38% (higher).

CROIC

10.30 %

YoY

49.38%

Last updated:

Cash Return on Invested Capital (CROIC) of Vytrus Biotech is 2025 10.30 % . Cash Return on Invested Capital (CROIC) of Vytrus Biotech was 2024 6.90 % . It decreases by 49.38% higher compared to the previous year.

The Vytrus Biotech CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2020
-8.59 EUR
Jan 1, 2021
3.53 EUR
Jan 1, 2022
-4.89 EUR
Jan 1, 2023
-3.42 EUR
Jan 1, 2024
6.90 EUR
Jan 1, 2025
10.30 EUR
The Vytrus Biotech CROIC history
YEARCROICYoY
10.30 %+49.38%
6.90 %-301.72%
-3.42 %-30.15%
-4.89 %-238.67%
3.53 %-141.07%
-8.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vytrus Biotech Stock analysis

What does Vytrus Biotech do? Vytrus Biotech SA, based in Terrassa, Spain, develops cosmetic active ingredients using plant stem cell technology. The company, listed on 24 March 2022, focuses on creating high-value natural active ingredients for the cosmetics and pharmaceutical sectors through industrial-scale production of bioactive molecules derived from plant cell cultures. With 29 employees, Vytrus targets dermo-cosmetics, veterinary medicine, and functional food, achieving over 99% resource savings compared to traditional methods. Vytrus Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vytrus Biotech stock

Cash Return on Invested Capital (CROIC) of Vytrus Biotech is 10.30 % in 2025.

Cash Return on Invested Capital (CROIC) of Vytrus Biotech changed from 6.90 % to 10.30 %, representing a 49.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Vytrus Biotech since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Vytrus Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Vytrus Biotech

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Vytrus Biotech